Alitretinoin Patent Expiration
Alitretinoin is Used for treating cutaneous lesions in patients with AIDS-related Kaposi's sarcoma. It was first introduced by Concordia Pharmaceuticals Inc
Alitretinoin Patents
Given below is the list of patents protecting Alitretinoin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Panretin | US5932622 | Method for in vivo modulation of non-malignant skin-related processes with 9-cis-retinoic acid |
Aug 03, 2016
(Expired) | Concordia |
Alitretinoin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List